Status:
UNKNOWN
Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19
Lead Sponsor:
Izmir Bakircay University
Collaborating Sponsors:
Cigli Regional Training Hospital
Muğla Sıtkı Koçman University
Conditions:
Covid19
Diabetes Mellitus, Type 2
Eligibility:
All Genders
35-65 years
Brief Summary
It is known that COVID-19 has a more negative clinical course and causes higher degrees of morbidity and mortality in case of COVID-19 in diabetic patients. However, the contribution of COVID-19 to hy...
Detailed Description
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) results in significantly higher morbidity and mortality in patients with concomi...
Eligibility Criteria
Inclusion
- To voluntarily participate in the study
- To be diagnosed with both Type II diabetes and COVID-19 for Group I
- To be diagnosed with COVID-19 for Group II
- Not having any diagnosed chronic diseases for Group III
Exclusion
- Patients who do not need hospitalization
- Patients with a diagnosis of Type I Diabetes Mellitus
- Patients diagnosed with renal failure and/or heart failure
- Being pregnant
- Body mass index over 40kg/m2
Key Trial Info
Start Date :
January 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04695158
Start Date
January 6 2021
End Date
March 1 2021
Last Update
February 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kadirhan Ozdemir
Izmir, Turkey (Türkiye), 06580